Vasodilatory prostaglandins in perinatal hypoxic brain damage

Darinka Sumanović-Glamuzina1, Filip Culo, Melanie-Ivana Culo

  • 1Neonatology and Intensive Care Unit of the Children's Department, University Hospital Mostar, Mostar, Bosnia and Herzegovina dara.glamuzina@tel.net.ba

Insights

Prostaglandin levels in cerebrospinal fluid were elevated in neonates with perinatal hypoxia. However, these elevated prostaglandin levels did not correlate with hypoxic-ischemic encephalopathy stage or long-term neurological outcomes.

Area of Science:

  • Biochemistry
  • Neonatal Medicine
  • Neuroscience

Background:

  • Perinatal hypoxia can lead to hypoxic-ischemic encephalopathy (HIE) in neonates.
  • Prostaglandins (PGE2 and PGI2) are implicated in inflammatory and neurological processes.
  • Understanding prostaglandin involvement in neonatal hypoxia is crucial for assessing brain injury.

Purpose of the Study:

  • To measure prostaglandin E2 (PGE2) and prostaglandin I2 (PGI2) levels in cerebrospinal fluid (CSF) and serum of neonates with perinatal hypoxia (PNH).
  • To correlate these prostaglandin levels with the severity of hypoxic-ischemic encephalopathy (HIE) and 12-month neurological outcomes.
  • To compare prostaglandin levels in hypoxic neonates with a control group.

Main Methods:

  • Enzyme Linked Immunosorbent Assay (ELISA) was used to quantify PGE2 and PGI2.
  • CSF and serum samples were collected from 19 hypoxic neonates (5-96 hours old).
  • A control group of 8 infants with suspected meningitis was included.

Main Results:

  • Significantly higher concentrations of PGE2 and PGI2 were found in the CSF of neonates with PNH compared to controls.
  • Serum PGI2 levels were significantly higher than CSF PGI2 levels in PNH patients.
  • No statistically significant correlation was observed between prostaglandin levels and HIE stage or 12-month neurological findings.

Conclusions:

  • Neonates experiencing perinatal hypoxia exhibit elevated CSF prostaglandin levels.
  • Elevated prostaglandins in PNH do not appear to predict HIE severity or long-term neurological deficits at 12 months.
  • Further research is needed to elucidate the precise role of prostaglandins in neonatal hypoxic brain injury.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...